{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:25:03Z","timestamp":1793917503554,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.taap.2026.118073","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:10:14Z","timestamp":1791414614000},"page":"118073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Morin mitigates doxorubicin-induced cardiotoxicity via suppression of oxidative stress, inflammation, and structural remodeling"],"prefix":"10.1016","volume":"517","author":[{"given":"Sanaa H.","family":"Elsayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagui H.","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar H.","family":"Elsharkawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yomna I.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.118073_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238589","article-title":"Farnesol protects against cardiotoxicity caused by doxorubicin-induced stress, inflammation, and cell death: an in vivo study in wistar rats","volume":"27","author":"Alkhanjaf","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2026.118073_bb0010","first-page":"1789","article-title":"Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis","volume":"60","author":"Arola","year":"2000","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.taap.2026.118073_bb0015","article-title":"Echocardiographic evaluation of cardiac function in ischemic rats: value of m-mode echocardiography","volume":"3","author":"Azar","year":"2014","journal-title":"Res. Cardiovasc. Med."},{"key":"10.1016\/j.taap.2026.118073_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2023.100264","article-title":"Morin: a comprehensive review on its versatile biological activity and associated therapeutic potential in treating cancers","volume":"7","author":"Balaga","year":"2023","journal-title":"Pharmacol. Res. - Mod. Chin. Med."},{"key":"10.1016\/j.taap.2026.118073_bb0025","article-title":"Doxorubicin-induced cardiotoxicity and risk factors","volume":"50","author":"Belger","year":"2024","journal-title":"IJC Heart Vasc."},{"key":"10.1016\/j.taap.2026.118073_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/eurheartjsupp\/suad062","article-title":"Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect?","volume":"25","author":"Bisceglia","year":"2023","journal-title":"Eur. Heart J. Suppl."},{"issue":"11","key":"10.1016\/j.taap.2026.118073_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115136","article-title":"Synbiotic supplementation attenuates doxorubicin-induced oxidative stress and inflammation in the gut-heart axis of chemotherapy-treated mice","volume":"26","author":"Cheng","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.taap.2026.118073_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ani11030886","article-title":"Date palm pollen extract avert doxorubicin-induced cardiomyopathy fibrosis and associated oxidative\/nitrosative stress, inflammatory cascade, and apoptosis-targeting Bax\/Bcl-2 and Caspase-3 signaling pathways","volume":"11","author":"Elblehi","year":"2021","journal-title":"Animals"},{"key":"10.1016\/j.taap.2026.118073_bb0045","doi-asserted-by":"crossref","first-page":"49808","DOI":"10.1007\/s11356-021-14049-4","article-title":"Morin protects against acrylamide-induced neurotoxicity in rats: an investigation into different signal pathways","volume":"28","author":"Gur","year":"2021","journal-title":"Environ.Sci. Pollut. Res. Int."},{"key":"10.1016\/j.taap.2026.118073_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4196\/kjpp.2021.25.3.177","article-title":"Morin alleviates fructose-induced metabolic syndrome in rats via ameliorating oxidative stress, inflammatory and fibrotic markers","volume":"25","author":"Heeba","year":"2021","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2026.118073_bb0055","article-title":"A systematic review of the potential chemoprotective effects of resveratrol on doxorubicin-induced cardiotoxicity: focus on the antioxidant, antiapoptotic, and anti-inflammatory activities","volume":"1","author":"Hu","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.taap.2026.118073_bb0060","first-page":"1","article-title":"Morin, as a natural flavonoid, provides promising influences against cardiovascular diseases","author":"Khademi","year":"2025","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.taap.2026.118073_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd9080259","article-title":"Cardioprotective strategies from cardiotoxicity in cancer patients: a comprehensive review","volume":"9","author":"Kourek","year":"2022","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.taap.2026.118073_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00056","article-title":"Review on the role of epigenetic modifications in doxorubicin-induced cardiotoxicity","volume":"7","author":"Kumari","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.taap.2026.118073_bb0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopha.2018.06.161","article-title":"Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidativestress, inflammation and apoptosis","volume":"106","author":"Kuzu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2026.118073_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cbi.2019.05.017","article-title":"Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats","volume":"308","author":"Kuzu","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2026.118073_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-019-2771-6","article-title":"Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling","volume":"19","author":"Li","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.taap.2026.118073_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ehjdh\/ztaa009","article-title":"Increased myocardial stiffness more than impaired relaxation function limits cardiac performance during exercise in heart failure with preserved ejection fraction: a virtual patient study","volume":"1","author":"van Loon","year":"2020","journal-title":"Eur. Heart J. Digit. Health"},{"key":"10.1016\/j.taap.2026.118073_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.phrs.2015.12.016","article-title":"CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism","volume":"105","author":"Maayah","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2026.118073_bb0100","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s12010-024-05141-9","article-title":"Metformin alleviates doxorubicin-induced cardiotoxicity via preserving mitochondrial dynamics balance and calcium homeostasis","volume":"197","author":"Maghraby","year":"2025","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.taap.2026.118073_bb0105","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2147\/VHRM.S381485","article-title":"Evaluation of ameliorative effect of quercetin and candesartan in doxorubicin-induced cardiotoxicity","author":"Majhi","year":"2022","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.taap.2026.118073_bb0110","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10741-020-09952-w","article-title":"Cardiac imaging in cardiotoxicity: a focus on clinical practice","volume":"26","author":"Makavos","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.taap.2026.118073_bb0115","article-title":"Dual therapy with allicin and metformin provides superior cardioprotection against doxorubicin-induced cardiotoxicity in rats compared to monotherapy","volume":"16","author":"Mojamel","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118073_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114917","article-title":"Indole-3-acetic acid exposure leads to cardiovascular inflammation and fibrosis in chronic kidney disease rat model","volume":"192","author":"Nayak","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2026.118073_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2024.104479","article-title":"Indole-3-acetic acid induced cardiogenesis impairment in in-vivo zebrafish via oxidative stress and downregulation of cardiac morphogenic factors","volume":"109","author":"Nayak","year":"2024","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"7","key":"10.1016\/j.taap.2026.118073_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073201","article-title":"Multifaceted cardioprotective potential of reduced glutathione against doxorubicin-induced cardiotoxicity via modulating inflammation\u2013oxidative stress axis","volume":"26","author":"Negm","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.118073_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2017.00005","article-title":"Assessment of diastolic function in congenital heart disease","volume":"4","author":"Panesar","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.taap.2026.118073_bb0140","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehaa013","article-title":"\u2018Cardiotoxicity\u2019: time to define new targets?","volume":"41","author":"Pardo Sanz","year":"2020","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.taap.2026.118073_bb0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12012-026-10150-7","article-title":"Effects of low-intensity aerobic training on cardiac dysfunction and myocardial fibrosis induced by doxorubicin in Wistar rats","volume":"26","author":"Pereira","year":"2026","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.taap.2026.118073_bb0150","article-title":"Protective effect of Qiliqiangxin against doxorubicin-induced cardiomyopathy by suppressing excessive autophagy and apoptosis","volume":"1","author":"Qin","year":"2022","journal-title":"Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.taap.2026.118073_bb0155","article-title":"Effects of injectable anesthetic combinations on left ventricular function and cardiac morphology in Sprague\u2013Dawley rats","volume":"52","author":"Sabatini","year":"2013","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.taap.2026.118073_bb0160","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2021.2019504","article-title":"Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway","volume":"11","author":"Shabaan","year":"2023","journal-title":"Tissue Barriers."},{"key":"10.1016\/j.taap.2026.118073_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2024.104543","article-title":"Morin attenuates sepsis-induced acute kidney injury by regulating inflammatory responses, oxidative stress and tubular regeneration (morin and sepsis-induced acute kidney injury)","volume":"111","author":"Shehata","year":"2024","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2026.118073_bb0170","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00726-023-03261-w","article-title":"Glycine protects against doxorubicin-induced heart toxicity in mice","volume":"55","author":"Shosha","year":"2023","journal-title":"Amino Acids"},{"key":"10.1016\/j.taap.2026.118073_bb0175","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1039\/D0FO01444C","article-title":"Morin as an imminent functional food ingredient: an update on its enhanced efficacy in the treatment and prevention of metabolic syndromes","volume":"11","author":"Thakur","year":"2020","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.taap.2026.118073_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s42826-024-00190-x","article-title":"Morin ameliorates myocardial injury in diabetic rats via modulation of inflammatory pathways","volume":"40","author":"Verma","year":"2024","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.taap.2026.118073_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.echo.2003.10.010","article-title":"Baseline echocardiographic values for adult male rats","volume":"17","author":"Watson","year":"2004","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"5","key":"10.1016\/j.taap.2026.118073_bb0190","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12012-020-09576-4","article-title":"Involvement of ROS\/NLRP3 inflammasome signaling pathway in doxorubicin-induced cardiotoxicity","volume":"20","author":"Wei","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.taap.2026.118073_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110525","article-title":"NF-\u03baB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity","volume":"130","author":"Xu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2026.118073_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117117","article-title":"Herbacetin mitigates oxidative stress and ferroptosis to protect against doxorubicin-induced cardiotoxicity","volume":"240","author":"Yang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2026.118073_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.929302","article-title":"Danhong injection attenuates doxorubicin-induced cardiotoxicity in rats via suppression of apoptosis: network pharmacology analysis and experimental validation","volume":"13","author":"Yi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118073_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172561","article-title":"Morin induces endothelium-dependent relaxation by activating TRPV4 channels in rat mesenteric arteries","volume":"859","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2026.118073_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.71016","article-title":"TRIM52 protects against doxorubicin-induced cardiac inflammation, oxidative stress and cardiac injury","volume":"30","author":"Zhang","year":"2026","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.taap.2026.118073_bb0220","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.2147\/DMSO.S476867","article-title":"Morin ameliorates myocardial injury in diabetic rats via modulation of autophagy, apoptosis, inflammation, and oxidative stress","author":"Zhu","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.taap.2026.118073_bb0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10557-022-07389-x","article-title":"Calsyntenin-1 promotes doxorubicin-induced dilated cardiomyopathy in rats","volume":"38","author":"Zhu","year":"2024","journal-title":"Cardiovasc. Drugs Ther."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:50:50Z","timestamp":1793915450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26003698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":45,"alternative-id":["S0041008X26003698"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.118073","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morin mitigates doxorubicin-induced cardiotoxicity via suppression of oxidative stress, inflammation, and structural remodeling","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.118073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118073"}}